๐ฌ Current Disease Focus:
Task Progress: 0%
๐ฅ Active Problem Solvers
0
๐ Experts collaborating globally
โก Current Task Assignment
๐งฌ Genetic Analysis
๐ Matching experts to specific tasks
๐ Resource Allocation by Research Phase:
๐ Data Analysis
๐งช Experimental Design
๐ฌ Clinical Trials
๐ Treatment Development
This study employs a multicenter, randomized, open-label, positive drug-con...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-03-01
Trial ID
NCT06854276
This is a Phase IV, randomized, active-controlled, open-label, parallel des...
Status
Completed
Location
Research Site
Start Date
2021-02-22
Trial ID
NCT04655027
Treatments Being Tested
High recombinant human erythropoietin requirement and elevated serum adipon...
Status
Completed
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT00308698
This study will evaluate the efficacy and tolerability of subcutaneous (SC)...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT02767765
Treatments Being Tested
Epo increases red blood cell production and hence the amount of oxygen that...
Status
Completed
Location
Aarhus University Hospital
Start Date
2011-08
Trial ID
NCT01320449
Treatments Being Tested
The study hypothesis that treatment with Erythropoietin (EPO) combined with...
Status
Unknown
Location
hematology clinic ,pediatrics hospital, Ain Shams University hospital
Start Date
2012-06
Trial ID
NCT01624038
Treatments Being Tested
A phase 2, randomized, open label, active comparator parallel controlled st...
Status
Unknown
Location
The general hospital of the people's liberation army
Start Date
2019-06-24
Trial ID
NCT03950687
The purpose of this study is to validate a Patient Satisfaction Questionnai...
Status
Completed
Location
Multiple Locations
Start Date
2002-10
Trial ID
NCT00120679
Treatments Being Tested
This will be a randomised control trial designed to test the effectiveness ...
Status
Unknown
Location
Hematology-Oncology Center
Start Date
2019-01-14
Trial ID
NCT03683810
Treatments Being Tested
Sarcopenia, abbreviated as muscle loss, is a prevalent complication among p...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-10
Trial ID
NCT07162090
Treatments Being Tested